Managers
Private investor clients of Connection Capital, the specialist private client investment business, have invested GBP6.75 million in MatOrtho, to support its international growth and product development.
Founded in 2010, MatOrtho designs, manufactures and commercialises performance leading, orthopaedic implant devices. It is one of the UK’s most innovative orthopaedic device designers. The company has achieved strong growth and has built a truly global presence, supplying implant devices into many of the world’s orthopaedic markets.
MatOrtho’s mission is improving the quality of life of all patients who receive one of its devices. Based in Leatherhead, the company has an international reputation
Tikehau Capital, a global alternative asset management group, has completed the acquisition of a qualified minority stake in Ecopol, a fast-growing manufacturer of water-soluble and biodegradable films for household single-dose detergents.
Carbone, Ecopol CEO will retain the control of the Company and benefit from Tikehau Capital support to further accelerate and strengthen its development plan.
“I’m delighted to announce Tikehau Capital’s investment in Ecopol. This partnership strengthens our shareholders’ base and our ability to achieve our ambitious targets. We have grown significantly over the last three years thanks to our commitment to develop a high-quality film and to the support
LGT Capital Partners has held final close of Crown Global Secondaries V (CGS V), its fifth private equity investment programme investing globally in secondaries, at the hard cap of USD4.5 billion.
The programmes’s investor base consists of more than 100 institutions, including pension funds, endowments, insurers, sovereign wealth funds, family offices and financial institutions in Europe, the Americas, the Middle East, Asia, Australia and New Zealand.
André Aubert, Partner at LGT Capital Partners, says: “With CGS V, we continue to see increasing appetite from institutional investors globally for secondaries, together with our successful investment strategy and results from predecessor funds.
Hertility Health, a new women’s health start-up revolutionising the world of hormone and reproductive health, has closed a GBP4.2 million seed funding round led by LocalGlobe, Venrex, and some key angel investors including former CEO of Bupa, Evelyn Bourke, and CEO of Nested and the unicorn company GoCardless, Matt Robinson.
The funds will help Hertility Health expand its current product offering of fertility and hormone testing, menopause, miscarriage, postnatal care, polycyctic ovarian syndrome (PCOS) and endometriosis testing, as well as aid the expansion of its current clinical trials which aim to reduce the diagnosis time for some of the most
Novo Holdings A/S, a global life sciences investor, has acquired BBI Group (BBI), a supplier of products and services to the global diagnostics and life sciences industries, from Exponent for an enterprise value of over GBP400 million.
Novo Holdings will be the majority shareholder of the company.
Founded in 1986, BBI provides critical reagents and immunoassay development, lateral flow development, diagnostic manufacturing services, and smartphone reader technologies to a global blue-chip customer base that includes Thermo-Fisher, Merck and Siemens. The company’s market-leading brand, BBI Solutions, provides a range of products, including antibodies, antigens, labels, complementary reagents and point of
Clessidra Private Equity SGR, a management company in the Italian private equity market, has held the first successful closing of Clessidra Capital Partners 4 fund, closed-type alternative investment fund.
The placement reached about EUR270 million and has registered a significant participation of subscribers from previous funds. Amongst the investors, some of the primary Italian institutional players, including Cassa Forense and Fondo Italiano d’Investimento as cornerstone investors.
As for Clessidra Capital Partners 3 fund, Italmobiliare SpA will be the sponsor of the fourth fund, with a commitment of 75 million euros to the first closing.
Next stages
Vital Capital, an impact investor that has been working with companies in sub-Saharan Africa for more than a decade, has approved two new loans from its Vital Impact Relief Facility (VIRF), which was launched last year to help fundamentally sound African businesses navigate short-term challenges.
The two loans were made to Sollatek, a leading manufacturer of solar and voltage control products, and Privamnuts, a macadamia nut processor and exporter which is leading the modernisation of the macadamia industry in Kenya. Both companies are examples of promising and successful private enterprises that are bringing about positive economic and social impact to
Coupay has secured GBP200,000 pre-seed funding from early-stage venture capitalist SFC Capital and leading tech founders and angels including serial entrepreneur Will Wynne of Smart Pension, Arena Flowers and Trulience.
Based out of London, Coupay leverages Open Banking and user insights to help small businesses, freelancers and the self-employed get paid securely, but smarter, quicker and more conveniently.
Coupay’s mission is to help small businesses get from sales to cash faster. They do this by delivering a low-cost, hugely scalable invoicing and payments platform through which businesses can send ‘Smart Invoices’ that allow their customers to pay them by bank
Upflow has raised USD15 million to ‘revolutionise’ how B2B companies get paid. The company provides a SaaS solution that enables companies to radically modernise their entire cash-cycle, and effortlessly collect customer payments. Upflow now processes more than USD200 million worth of invoices a month, for over 1.5 million transacting companies.
The funding round includes participation from 9yards Capital and existing investor eFounders. Several industry-leading angel investors also participated, including N26 CoFounder Maximilian Tayenthal; SVP Delivery, Pierre-Dimitri Gore-Coty of Uber; and Raffael Johnen, Co-Founder & CEO at auxmoney. As part of the transaction, the former co-founder and co-CEO of Westwing, Andrew
TA Associates, a global growth private equity firm is to sell Paula’s Choice, a leading digital-led skin care brand, to Unilever, one of the world’s leading suppliers of Beauty & Personal Care, Home Care, and Foods & Refreshment products. Terms of the transaction, which is expected to close in the third quarter of 2021, have not been disclosed.
Paula’s Choice is one of the largest digitally native beauty brands in the world. Founded more than 25 years ago by one of the original beauty influencers, Paula Begoun, Paula’s Choice has grown into a leading global skin care brand with a
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
